Search Results - "Dubow, Jordan"

S2236 Life After Celiac Disease Diagnosis: Results from the Go Beyond Celiac Patient Registry by Miller, Erin B. P., Dubow, Jordan, Avery, Kate, Ratner, Amy, Silberg, Debra G.

Get full text

S2237 Frequency and Severity of Gastrointestinal and Extra-Gastrointestinal Manifestations of Celiac Disease: Data From the Go Beyond Celiac Patient Registry by Miller, Erin B. P., Dubow, Jordan, Avery, Kate, Ratner, Amy, Silberg, Debra G.

Get full text

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy by Griggs, Robert C, Miller, J Phillip, Greenberg, Cheryl R, Fehlings, Darcy L, Pestronk, Alan, Mendell, Jerry R, Moxley, Richard T, King, Wendy, Kissel, John T, Cwik, Valerie, Vanasse, Michel, Florence, Julaine M, Pandya, Shree, Dubow, Jordan S, Meyer, James M

“…OBJECTIVE:To assess safety and efficacy of deflazacort (DFZ) and prednisone (PRED) vs placebo in Duchenne muscular dystrophy (DMD). METHODS:This phase III,…”
Get full text

Ecopipam for Tourette Syndrome: A Randomized Trial by Gilbert, Donald L, Dubow, Jordan S, Cunniff, Timothy M, Wanaski, Stephen P, Atkinson, Sarah D, Mahableshwarkar, Atul R

“…All US Food and Drug Administration-approved medications for Tourette syndrome are antipsychotics, and their use is limited by the risk of weight gain,…”
Get full text

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results by Fernandez, Hubert H., Standaert, David G., Hauser, Robert A., Lang, Anthony E., Fung, Victor S.C., Klostermann, Fabian, Lew, Mark F., Odin, Per, Steiger, Malcolm, Yakupov, Eduard Z., Chouinard, Sylvain, Suchowersky, Oksana, Dubow, Jordan, Hall, Coleen M., Chatamra, Krai, Robieson, Weining Z., Benesh, Janet A., Espay, Alberto J.

“…ABSTRACT Motor complications in Parkinson's disease (PD) are associated with long‐term oral levodopa treatment and linked to pulsatile dopaminergic…”
Get full text

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials by Lang, Anthony E., Rodriguez, Ramon L., Boyd, James T., Chouinard, Sylvain, Zadikoff, Cindy, Espay, Alberto J., Slevin, John T., Fernandez, Hubert H., Lew, Mark F., Stein, David A., Odin, Per, Fung, Victor S.C., Klostermann, Fabian, Fasano, Alfonso, Draganov, Peter V., Schmulewitz, Nathan, Robieson, Weining Z., Eaton, Susan, Chatamra, Krai, Benesh, Janet A., Dubow, Jordan

“…ABSTRACT Background Continuous administration of levodopa‐carbidopa intestinal gel (carbidopa‐levodopa enteral suspension) through a percutaneous endoscopic…”
Get full text

Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients by Slevin, John T, Fernandez, Hubert H, Zadikoff, Cindy, Hall, Coleen, Eaton, Susan, Dubow, Jordan, Chatamra, Krai, Benesh, Janet

“…Levodopa-carbidopa intestinal gel (LCIG) is delivered continuously via intrajejunal percutaneous gastrostomy tube. To examine long-term safety, efficacy and…”
Get more information

RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates by Roy, Asim, Stern, Thomas, Harsh, John, Hudson, J. Douglas, Ajayi, Akinyemi O., Corser, Bruce C., Mignot, Emmanuel, Santamaria, Adrian, Morse, Anne Marie, Abaluck, Brian, Ibrahim, Sally, Schweitzer, Paula K., Lancaster, Katie, Dubow, Jordan, Gudeman, Jennifer

“…Preference for extended-release, once-nightly sodium oxybate (ON-SXB, FT218) vs twice-nightly immediate-release (IR) oxybate was assessed in participants…”
Get full text

Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials by Lew, Mark F, Slevin, John T, Krüger, Rejko, Martínez Castrillo, Juan Carlos, Chatamra, Krai, Dubow, Jordan S, Robieson, Weining Z, Benesh, Janet A, Fung, Victor S.C

“…Abstract Background Levodopa-carbidopa intestinal gel (LCIG) provides continuous infusion and reduces “off” time in advanced Parkinson's disease (PD) patients…”
Get full text

Rhomboencephalitis due to cocaine-induced bony erosion of skull base by DUBOW, Jordan S, SINGER, Samuel, SEGAL, Alan Z

Get full text

Mechanism of Acute Ischemic Stroke in Patients with Severe Middle Cerebral Artery Atherosclerotic Disease by Dubow, Jordan S., MD, Salamon, Elliott, DO, Greenberg, Edward, MD, Patsalides, Athos, MD

“…Background Intracranial atherosclerotic disease (ICAD) is one of the most common causes of ischemic stroke worldwide. Although the pathogenesis of cerebral…”
Get full text

Autonomic Dysfunction in Parkinson’s Disease by Dubow, Jordan S., MD

Get full text

Reversible corneal edema associated with amantadine use: An unrecognized problem by Dubow, Jordan S., Rezak, Michael, Berman, Andrew A.

Get full text

Isolated navicular fracture presenting as stiff limb syndrome: A case report by Dubow, Jordan S., Zadikoff, Cindy

Get full text

Epilepsy in sports and recreation by DUBOW, Jordan S, KELLY, James P

“…In the US, millions of people participate in physical activity on a regular basis. However, among the many people with epilepsy, few incorporate exercise into…”
Get full text

Acute chorea associated with metoclopramide use by Dubow, Jordan S, Leikin, Jerrold, Rezak, Michael

“…Metoclopramide is a dopamine receptor antagonist that is used to treat diabetic gastroparesis, chemotherapy-induced nausea, and migraines. It is known to cause…”
Get full text

Acute dystonic reaction associated with foscarnet administration by Dubow, Jordan S, Panush, Stephanie R, Rezak, Michael, Leikin, Jerrold

“…Drug-induced movement disorders are commonly seen in the inpatient setting and outpatient movement disorders centers. The most common acute reactions are…”
Get full text

Status epilepticus due to tiagabine ingestion by Leikin, Jerrold B, Benigno, Jennifer, Dubow, Jordan S, Fisher, Mark

“…Tiagabine, in excess dosing scenarios, has been rarely documented to cause status epilepticus. We describe such a case that was not responsive to…”
Get full text

Pharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy Adults by Seiden, David, Tyler, Charles, Dubow, Jordan

“…FT218 is an investigational, once-nightly, modified-release formulation of sodium oxybate (SO). SO effectively treats excessive daytime sleepiness and…”
Get full text

Randomized Controlled Trials in Celiac Disease: Expressing the Patient’s Voice by Silberg, Debra G., Dubow, Jordan, Bast, Alice

Get full text